JP2024518319A5 - - Google Patents

Info

Publication number
JP2024518319A5
JP2024518319A5 JP2023565467A JP2023565467A JP2024518319A5 JP 2024518319 A5 JP2024518319 A5 JP 2024518319A5 JP 2023565467 A JP2023565467 A JP 2023565467A JP 2023565467 A JP2023565467 A JP 2023565467A JP 2024518319 A5 JP2024518319 A5 JP 2024518319A5
Authority
JP
Japan
Prior art keywords
acid
organic solvent
radiopharmaceutical composition
proportion
mobile phase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023565467A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024518319A (ja
Filing date
Publication date
Priority claimed from GBGB2105950.6A external-priority patent/GB202105950D0/en
Application filed filed Critical
Publication of JP2024518319A publication Critical patent/JP2024518319A/ja
Publication of JP2024518319A5 publication Critical patent/JP2024518319A5/ja
Pending legal-status Critical Current

Links

JP2023565467A 2021-04-26 2022-04-26 分析用ｈｐｌｃ Pending JP2024518319A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB2105950.6 2021-04-26
GBGB2105950.6A GB202105950D0 (en) 2021-04-26 2021-04-26 Analytical HPLC
PCT/EP2022/061004 WO2022229155A1 (en) 2021-04-26 2022-04-26 Analytical hplc

Publications (2)

Publication Number Publication Date
JP2024518319A JP2024518319A (ja) 2024-05-01
JP2024518319A5 true JP2024518319A5 (enExample) 2025-05-09

Family

ID=76193425

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023565467A Pending JP2024518319A (ja) 2021-04-26 2022-04-26 分析用ｈｐｌｃ

Country Status (12)

Country Link
US (1) US20240302338A1 (enExample)
EP (1) EP4330662B1 (enExample)
JP (1) JP2024518319A (enExample)
KR (1) KR20240000562A (enExample)
CN (1) CN117222890A (enExample)
AU (1) AU2022264815A1 (enExample)
CA (1) CA3217818A1 (enExample)
ES (1) ES3050308T3 (enExample)
GB (1) GB202105950D0 (enExample)
IL (1) IL307946A (enExample)
PL (1) PL4330662T3 (enExample)
WO (1) WO2022229155A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201915206D0 (en) 2019-10-21 2019-12-04 Ge Healthcare Ltd Use of cyclodextrins as a radiostabilizer
CN119688861A (zh) * 2024-11-29 2025-03-25 中国辐射防护研究院 一种生物样本中18f-psma-1007放化纯的液相色谱分析方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5300280A (en) * 1992-02-14 1994-04-05 Mallinckrodt Medical, Inc. Stabilized radiopharmaceutical kits
ES2398393T3 (es) * 2002-03-01 2013-03-15 Dyax Corp. Péptidos de unión a KDR y a VEGF/KDR y su uso en diagnóstico y terapia
JP4942953B2 (ja) * 2005-06-30 2012-05-30 サントリーホールディングス株式会社 プロシアニジンの分析方法
US8214159B2 (en) * 2008-12-04 2012-07-03 Siemens Medical Solutions Usa, Inc. Apparatus and method for automated quality control
GB201013808D0 (en) * 2010-08-18 2010-09-29 Ge Healthcare Ltd Peptide radiotracer compositions
EP2450332A1 (en) * 2010-10-22 2012-05-09 Bayer Pharma Aktiengesellschaft Compounds for use in Imaging, diagnosing and/or treatment of diseases of the central nervous system (F-D2-Deprenyl)
GB201202420D0 (en) * 2012-02-13 2012-03-28 Ge Healthcare Ltd Radiotracer compositions
CN104718299B (zh) * 2012-08-13 2024-02-06 通用医院公司 用于线粒体复合物i的定量定位的系统和方法
GB201303830D0 (en) * 2013-03-04 2013-04-17 Univ Glasgow Methods,unit and device relating to the manufacture,processing,synthesising or screening of radiopharmaceutical compositions
GB201418893D0 (en) * 2014-10-23 2014-12-10 Univ Hull Monolithic body
GB201805253D0 (en) * 2018-03-29 2018-05-16 Ge Healthcare Ltd Ip Solid phase extraction
CN111333638A (zh) * 2020-03-17 2020-06-26 四川大学华西医院 18f标记的异喹啉并哒嗪酮类化合物及其合成方法和应用

Similar Documents

Publication Publication Date Title
JP2024518319A5 (enExample)
Rickmeier et al. Site‐Specific Deoxyfluorination of Small Peptides with [18F] Fluoride
Bowden et al. Scalable 18 F processing conditions for copper-mediated radiofluorination chemistry facilitate DoE optimization studies and afford an improved synthesis of [18 F] olaparib
Liu et al. A new 18 F-heteroaryltrifluoroborate radio-prosthetic with greatly enhanced stability that is labelled by 18 F–19 F-isotope exchange in good yield at high specific activity
JP2017526745A (ja) 金属阻害剤
EP3212610B1 (en) Methods for low temperature fluorine-18 radiolabeling of biomolecules
JP4846238B2 (ja) 放射線標識した化合物の精製方法
US20120288445A1 (en) Radiolabelling
US8968701B2 (en) Usage of low to medium-pressure liquid chromatography for the purification of radiotracers
Verhoog et al. Ring opening of epoxides with [18 F] FeF species to produce [18 F] fluorohydrin PET imaging agents
Björkman et al. Synthesis of a 11C‐labelled prostaglandin F2α analogue using an improved method for stille reactions with [11C] methyl iodide
JP2025116040A (ja) 放射性金属錯体の製造方法
EP4330662B1 (en) Analytical hplc
Shiue et al. Syntheses of no‐carrier‐added (NCA)[18F] fluoroalkyl halides and their application in the syntheses of [18F] fluoroalkyl derivatives of neurotransmitter receptor active compounds
Seo et al. Fast and easy drying method for the preparation of activated [18 F] fluoride using polymer cartridge
JP2021515005A5 (enExample)
US8377704B2 (en) Detection and quantification of anions
CN110305004B (zh) 放射性碘标记15-(4-碘苯基)-3(r,s)-甲基十五烷酸的制造方法
Wei et al. Synthesis and characterization of 123I-CMICE-013: a potential SPECT myocardial perfusion imaging agent
JP2024522770A5 (enExample)
Ryzhikov et al. Preparation of [18F] flumazenil, a potential radioligand for PET imaging of central benzodiazepine receptors, by isotope exchange
US20200047158A1 (en) Solid phase conditioning
Qin et al. Enantiomer separation of dimethyl dicarboxy α‐biphenyl (DDB) and its analogues on a covalently bonded cellulose tris‐(3, 5‐dimethylphenyl‐carbamate) CSP
EP4696686A1 (en) Fapi theranostic compounds assembled with tetrazine ligation
HK40109526B (en) Analytical hplc